Suppr超能文献

缺铁性贫血儿童铁治疗的障碍与促进因素。

Barriers to and Facilitators of Iron Therapy in Children with Iron Deficiency Anemia.

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, TX; Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.

Texas Children's Hospital, Houston, TX.

出版信息

J Pediatr. 2020 Apr;219:202-208. doi: 10.1016/j.jpeds.2019.12.040. Epub 2020 Jan 31.

Abstract

OBJECTIVE

To characterize barriers to and facilitators of successful iron therapy in young children with iron deficiency anemia (IDA) from an in-depth parental perspective.

STUDY DESIGN

Prospective, mixed methods study of children age 9 months to 4 years with a diagnosis of nutritional IDA by clinical history and laboratory criteria and their parents. Clinical data were obtained from the electronic health record. Semistructured interviews focused on knowledge of IDA, clinical effects, experience with iron therapies, and motivation were conducted with the parent who identified as the child's primary caregiver.

RESULTS

Twenty patient-parent dyads completed the study; 80% (n = 16) identified as Hispanic/Latino (white). Patients' median age was 23 months (50% male); median initial hemoglobin concentration was 8.2 g/dL and duration of oral iron therapy was 3 months. Parents' median age was 29 years (85% female); 8 interviews (40%) were conducted in Spanish. Barriers included difficulty in administering oral iron owing to side effects and poor taste. Facilitators included provision of specific instructions; support from healthcare providers and additional caregivers at home; motivation to benefit child's health, which was strengthened by strong emotional reactions (ie, stress, anxiety) to therapy and follow-up; and an appreciation of child's improvement with successful completion of therapy.

CONCLUSIONS

Our findings support the need for interventions designed to promote oral iron adherence in children with IDA. Rather than focusing on knowledge content related to IDA, interventions should aim to increase parental motivation by emphasizing the health benefits of adhering to iron therapy and avoiding more invasive interventions.

摘要

目的

从深入的父母角度描述缺铁性贫血 (IDA) 幼儿铁治疗成功的障碍和促进因素。

研究设计

前瞻性混合方法研究,纳入 9 个月至 4 岁有临床病史和实验室标准诊断为营养性 IDA 的儿童及其父母。临床数据来自电子健康记录。半结构化访谈重点关注 IDA 知识、临床效果、铁治疗经验和动机,访谈对象为被确定为孩子主要照顾者的父母。

结果

20 对患儿-家长完成了研究;80%(n=16)为西班牙裔/拉丁裔(白人)。患儿的中位年龄为 23 个月(50%为男性);初始血红蛋白浓度中位数为 8.2g/dL,口服铁治疗持续 3 个月。家长的中位年龄为 29 岁(85%为女性);8 次访谈(40%)以西班牙语进行。障碍包括因副作用和口味不佳导致口服铁剂难以服用。促进因素包括提供具体的指导;医护人员和其他家庭照顾者的支持;为了孩子的健康而产生的动力,这种动力因对治疗和随访的强烈情绪反应(例如,压力、焦虑)而增强;以及对孩子成功完成治疗后改善的欣赏。

结论

我们的研究结果支持需要干预措施来促进 IDA 儿童口服铁剂的依从性。干预措施不应侧重于与 IDA 相关的知识内容,而应通过强调坚持铁剂治疗和避免更具侵入性干预的健康益处来提高家长的动力。

相似文献

9
Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.静脉注射蔗糖铁治疗缺铁性贫血儿童
J Pediatr Hematol Oncol. 2017 Jul;39(5):e259-e262. doi: 10.1097/MPH.0000000000000879.

引用本文的文献

4
Iron Deficiency Anemia in Infancy, Childhood, and Adolescence.婴幼儿、儿童及青少年缺铁性贫血
Turk Arch Pediatr. 2023 Jul;58(4):358-362. doi: 10.5152/TurkArchPediatr.2023.23049.

本文引用的文献

1
Disorders of Iron Metabolism: New Diagnostic and Treatment Approaches to Iron Deficiency.铁代谢紊乱:缺铁的新诊断和治疗方法。
Hematol Oncol Clin North Am. 2019 Jun;33(3):393-408. doi: 10.1016/j.hoc.2019.01.006. Epub 2019 Mar 29.
2
4
Deficiencies in the Management of Iron Deficiency Anemia During Childhood.儿童缺铁性贫血管理中的不足之处。
Pediatr Blood Cancer. 2016 Apr;63(4):743-5. doi: 10.1002/pbc.25861. Epub 2016 Jan 5.
5
Diagnosis and management of iron deficiency anemia.缺铁性贫血的诊断与管理
Hematol Oncol Clin North Am. 2014 Aug;28(4):729-45, vi-vii. doi: 10.1016/j.hoc.2014.04.007. Epub 2014 Jun 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验